U.S., Feb. 21 -- ClinicalTrials.gov registry received information related to the study (NCT06836141) titled 'Biomarkers for Cognitive Decline in Intracerebral Hemorrhage' on Jan. 15.
Brief Summary: The goal of this clinical trial is to see if silent brain infarcts (SBIs), or stroke-like symptoms detectable during brain imaging, are a possible contributor to cognitive decline for patients diagnosed with spontaneous intracerebral hemorrhage (sICH), or blood clot in the brain. The main questions it aims to answer are
* if SBIs in sICH are associated with a lower cognitive level and more rapid cognitive decline
* if SBIs in sICH are associated with certain findings on brain imaging
* if SBIs in sICH are associated with higher inflammation m...